Pulmovant
The Manager, CMC Quality supports quality oversight of Pulmovant's vendors to ensure drug substance, drug product, and finished product are manufactured, tested, and released in compliance with cGMPs. This individual contributor role focuses on batch record review and product disposition for the company's global clinical development program. The position requires a hands-on, detail-oriented professional comfortable working in a small-company environment.
Pulmovant is a clinical-stage biopharmaceutical company singularly focused on developing innovative inhaled therapies for pulmonary diseases, including pulmonary hypertension. The company's lead candidate, mosliciguat, is a potentially first-in-class once-daily inhaled treatment with a differentiated soluble guanylate cyclase (sGC) activation mechanism. Pulmovant is advancing mosliciguat through clinical trials with the goal of transforming the treatment paradigm for patients with pulmonary diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Pulmovant.
Pulmovant completes enrollment for PH-ILD treatment trial
1 month ago